Capsid-expressing DNA in AAV vectors and its elimination by use of an oversize capsid gene for vector production

Gene Therapy

Volumn 18, Issue 4, 2011, Pages 411-417

  Halbert, C L ^a   Metzger, M J ^a   Lam, S L ^a   Miller, A D ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

AAV vectors; capsid gene transfer; vector immune responses

Indexed keywords

DNA; PARVOVIRUS VECTOR;

ARTICLE; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRION; VIRUS CAPSID;

CAPSID; CELLS, CULTURED; DEPENDOVIRUS; DNA, VIRAL; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; INTRONS; TRANSDUCTION, GENETIC;

ADENO-ASSOCIATED VIRUS; ANIMALIA; MIRIDAE;

EID: 79953793932     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2010.167     Document Type: Article

References (30)

1. Herzog RW, Yang EY, Couto LB, Hagstrom JN, Elwell D, Fields PA et al. Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector. Nat Med 1999; 5: 56-63. (Pubitemid 29050999)
2. Passini MA, Watson DJ, Vite CH, Landsburg DJ, Feigenbaum AL, Wolfe JH. Intraventricular brain injection of adeno-associated virus type 1 (AAV1) in neonatal mice results in complementary patterns of neuronal transduction to AAV2 and total long-term correction of storage lesions in the brains of b-glucuronidase-deficient mice. J Virol 2003; 77: 7034-7040. (Pubitemid 36666896)
3. Weber M, Rabinowitz J, Provost N, Conrath H, Folliot S, Briot D et al. Recombinant adeno-associated virus serotype 4 mediates unique and exclusive long-term transduc-tion of retinal pigmented epithelium in rat, dog, and nonhuman primate after subretinal delivery. Mol Ther 2003; 7: 774-781. (Pubitemid 36790254)
4. Mochizuki S, Mizukami H, Ogura T, Kure S, Ichinohe A, Kojima K et al. Long-term correction of hyperphenylalaninemia by AAV-mediated gene transfer leads to behavioral recovery in phenylketonuria mice. Gene Ther 2004; 11: 1081-1086. (Pubitemid 39023112)
5. Manno CS, Arruda VR, Pierce GF, Glader B, Ragni M, Rasko J et al. Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat Med 2006; 12: 342-347. (Pubitemid 43355084)
6. Mingozzi F, Meulenberg JJ, Hui DJ, Basner-Tschakarjan E, Hasbrouck NC, Edmonson SA et al. AAV-1-mediated gene transfer to skelet al muscle in humans results in dose-dependent activation of capsid-specific T cells. Blood 2009; 114: 2077-2086.
7. Wang Z, Kuhr CS, Allen JM, Blankinship M, Gregorevic P, Chamberlain JS et al. Sustained AAV-mediated dystrophin expression in a canine model of duchenne muscular dystrophy with a brief course of immunosuppression. Mol Ther 2007; 15: 1160-1166. (Pubitemid 46813619)
8. Halbert CL, Madtes DK, Vaughan AE, Wang Z, Storb R, Tapscott SJ et al. Expression of human a1-antitrypsin in mice and dogs following AAV6 vector-mediated gene transfer to the lungs. Mol Ther 2010; 18: 1165-1172.
9. Allen JM, Debelak DJ, Reynolds TC, Miller AD. Identification and elimination of replication-competent adeno-associated virus (AAV) that can arise by nonhomologous recombination during AAV vector production. J Virol 1997; 71: 6816-6822. (Pubitemid 27355342)
10. Cao L, Liu Y, During MJ, Xiao W. High-titer, wild-type free recombinant adeno-associated virus vector production using intron-containing helper plasmids. J Virol 2000; 74: 11456-11463. (Pubitemid 32222292)
11. Nony P, Chadeuf G, Tessier J, Moullier P, Salvetti A. Evidence for packaging of rep-cap sequences into adeno-associated virus (AAV) type 2 capsids in the absence of inverted terminal repeats: a model for generation of rep-positive AAV particles. J Virol 2003; 77: 776-781. (Pubitemid 36005019)
12. Chadeuf G, Ciron C, Moullier P, Salvetti A. Evidence for encapsidation of prokaryotic sequences during recombinant adeno-associated virus production and their in vivo persistence after vector delivery. Mol Ther 2005; 12: 744-753. (Pubitemid 41350156)
13. Hauck B, Murphy SL, Smith PH, Qu G, Liu X, Zelenaia O et al. Undetectable transcription of cap in a clinical AAV vector: implications for preformed capsid in immune responses. Mol Ther 2009; 17: 144-152.
14. Halbert CL, Allen JM, Miller AD. Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to that of AAV2 vectors. J Virol 2001; 75: 6615-6624. (Pubitemid 32578181)
15. Halbert CL, Lam SL, Miller AD. High-efficiency promoter-dependent transduction by adeno-associated virus type 6 vectors in mouse lung. Hum Gene Ther 2007; 18: 344-354. (Pubitemid 46709346)
16. Blankinship MJ, Gregorevic P, Allen JM, Harper SQ, Harper H, Halbert CL et al. Efficient transduction of skelet al muscle using vectors based on adeno-associated virus serotype 6. Mol Ther 2004; 10: 671-678. (Pubitemid 39272856)
17. Stieger K, Schroeder J, Provost N, Mendes-Madeira A, Belbellaa B, Le Meur G et al. Detection of intact rAAV particles up to 6 years after successful gene transfer in the retina of dogs and primates. Mol Ther 2009; 17: 516-523.
18. Allen JM, Halbert CL, Miller AD. Improved adeno-associated virus vector production with transfection of a single helper adenovirus gene, E4orf6. Mol Ther 2000; 1: 88-95.
19. Chadeuf G, Favre D, Tessier J, Provost N, Nony P, Kleinschmidt J et al. Efficient recombinant adeno-associated virus production by a stable rep-cap HeLa cell line correlates with adenovirus-induced amplification of the integrated rep-cap genome. J Gene Med 2000; 2: 260-268.
20. Liu X, Voulgaropoulou F, Chen R, Johnson PR, Clark KR. Selective Rep-Cap gene amplification as a mechanism for high-titer recombinant AAV production from stable cell lines. Mol Ther 2000; 2: 394-403.
21. Ayuso E, Mingozzi F, Montane J, Leon X, Anguela XM, Haurigot V et al. High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiency. Gene Ther 2010; 17: 503-510.
22. Duan D, Yue Y, Engelhardt JF. Expanding AAV packaging capacity with trans-splicing or overlapping vectors: a quantitative comparison. Mol Ther 2001; 4: 383-391. (Pubitemid 33040525)
23. Halbert CL, Allen JM, Miller AD. Efficient mouse airway transduction following recombination between AAV vectors carrying parts of a larger gene. Nat Biotechnol 2002; 20: 697-701. (Pubitemid 34734136)
24. Lai Y, Yue Y, Duan D. Evidence for the failure of adeno-associated virus serotype 5 to package a viral genome X8.2 kb. Mol Ther 2010; 18: 75-79.
25. Wu Z, Yang H, Colosi P. Effect of genome size on AAV vector packaging. Mol Ther 2010; 18: 80-86.
26. Dong B, Nakai H, Xiao W. Characterization of genome integrity for oversized recombi-nant AAV vector. Mol Ther 2010; 18: 87-92.
27. Gregorevic P, Blankinship MJ, Allen JM, Crawford RW, Meuse L, Miller DG et al. Systemic delivery of genes to striated muscles using adeno-associated viral vectors. Nat Med 2004; 10: 828-834. (Pubitemid 39070856)
28. Boissy R, Astell CR. An Escherichia coli recBCsbcBrecF host permits the deletion-resistant propagation of plasmid clones containing the 5-terminal palindrome of minute virus of mice. Gene 1985; 35: 179-185. (Pubitemid 15067260)
29. Halbert CL, Miller AD. AAV-mediated gene transfer to mouse lungs. Methods Mol Biol 2004; 246: 201-212.
30. Halbert CL, Standaert TA, Aitken ML, Alexander IE, Russell DW, Miller AD. Transduc-tion by adeno-associated virus vectors in the rabbit airway: efficiency, persistence, and readministration. J Virol 1997; 71: 5932-5941. (Pubitemid 27304930)